Progenics Pharmaceuticals Inc (NASDAQ:PGNX)

5.54
Delayed Data
As of May 27
 +0.35 / +6.74%
Today’s Change
3.31
Today|||52-Week Range
7.84
-26.72%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Revenue and IncomeNet Revenues1.5M41.7M-571.0K248.0K
 
 
 
 
 
Cost of Goods Sold327.0K329.0K27.0K42.0K
 
 
 
 
 
Depreciation And Amortization133.0K142.0K126.0K132.0K
 
 
 
 
 
 
Operating ExpensesGross Income1.0M41.2M-724.0K74.0K
 
 
 
 
 
General Expenses11.7M10.6M10.0M10.0M
 
 
 
 
 
Research And Development7.8M6.7M6.2M6.4M
 
 
 
 
 
Total Operating Expenses12.2M11.1M10.2M10.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-10.7M30.6M-10.8M-10.0M
 
 
 
 
 
Extraordinary Credit--7.3M----
 
 
Extraordinary Charge-400.0K-1.1M-2.2M-300.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-11.1M36.7M-12.9M-10.3M
 
 
 
 
 
Income Taxes-1.0K-227.0K-761.0K--
 
 
 
 
Net Income-11.1M37.0M-12.2M-10.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS63.7M69.6M69.6M69.6M
 
 
 
 
 
Shares To Calculate EPS Diluted63.7M72.9M69.6M69.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.17$0.51-$0.18-$0.15
 
 
 
 
 
EPS Diluted-$0.17$0.51-$0.18-$0.15
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account